Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

CYP2C19 variant mitigates Alzheimer disease pathophysiology in vivo and postmortem.

Benedet AL, Yu L, Labbe A, Mathotaarachchi S, Pascoal TA, Shin M, Kang MS, Gauthier S, Rouleau GA, Poirier J, Bennett DA, Rosa-Neto P; Alzheimer's Disease Neuroimaging Initiative.

Neurol Genet. 2018 Jan 30;4(1):e216. doi: 10.1212/NXG.0000000000000216. eCollection 2018 Feb.

PMID:
29473050
2.

Anosognosia predicts default mode network hypometabolism and clinical progression to dementia.

Therriault J, Ng KP, Pascoal TA, Mathotaarachchi S, Kang MS, Struyfs H, Shin M, Benedet AL, Walpola IC, Nair V, Gauthier S, Rosa-Neto P; Alzheimer's Disease Neuroimaging Initiative.

Neurology. 2018 Feb 14. pii: 10.1212/WNL.0000000000005120. doi: 10.1212/WNL.0000000000005120. [Epub ahead of print]

PMID:
29444971
3.

Amyloid and tau signatures of brain metabolic decline in preclinical Alzheimer's disease.

Pascoal TA, Mathotaarachchi S, Shin M, Park AY, Mohades S, Benedet AL, Kang MS, Massarweh G, Soucy JP, Gauthier S, Rosa-Neto P; Alzheimer’s Disease Neuroimaging Initiative.

Eur J Nucl Med Mol Imaging. 2018 Feb 2. doi: 10.1007/s00259-018-3933-3. [Epub ahead of print]

PMID:
29396637
4.

Fluid and imaging biomarkers for Alzheimer's disease: Where we stand and where to head to.

Henriques AD, Benedet AL, Camargos EF, Rosa-Neto P, Nóbrega OT.

Exp Gerontol. 2018 Jan 4. pii: S0531-5565(17)30411-4. doi: 10.1016/j.exger.2018.01.002. [Epub ahead of print] Review.

PMID:
29307736
5.

Identifying incipient dementia individuals using machine learning and amyloid imaging.

Mathotaarachchi S, Pascoal TA, Shin M, Benedet AL, Kang MS, Beaudry T, Fonov VS, Gauthier S, Rosa-Neto P; Alzheimer's Disease Neuroimaging Initiative.

Neurobiol Aging. 2017 Nov;59:80-90. doi: 10.1016/j.neurobiolaging.2017.06.027. Epub 2017 Jul 11.

6.

Neuropsychiatric symptoms predict hypometabolism in preclinical Alzheimer disease.

Ng KP, Pascoal TA, Mathotaarachchi S, Chung CO, Benedet AL, Shin M, Kang MS, Li X, Ba M, Kandiah N, Rosa-Neto P, Gauthier S; Alzheimer's Disease Neuroimaging Initiative.

Neurology. 2017 May 9;88(19):1814-1821. doi: 10.1212/WNL.0000000000003916. Epub 2017 Apr 12.

7.

Synergistic interaction between amyloid and tau predicts the progression to dementia.

Pascoal TA, Mathotaarachchi S, Shin M, Benedet AL, Mohades S, Wang S, Beaudry T, Kang MS, Soucy JP, Labbe A, Gauthier S, Rosa-Neto P; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2017 Jun;13(6):644-653. doi: 10.1016/j.jalz.2016.11.005. Epub 2016 Dec 23.

8.

Principal component of explained variance: An efficient and optimal data dimension reduction framework for association studies.

Turgeon M, Oualkacha K, Ciampi A, Miftah H, Dehghan G, Zanke BW, Benedet AL, Rosa-Neto P, Greenwood CM, Labbe A; Alzheimer’s Disease Neuroimaging Initiative.

Stat Methods Med Res. 2016 Jul 26. pii: 0962280216660128. [Epub ahead of print]

PMID:
27460538
9.

VoxelStats: A MATLAB Package for Multi-Modal Voxel-Wise Brain Image Analysis.

Mathotaarachchi S, Wang S, Shin M, Pascoal TA, Benedet AL, Kang MS, Beaudry T, Fonov VS, Gauthier S, Labbe A, Rosa-Neto P.

Front Neuroinform. 2016 Jun 15;10:20. doi: 10.3389/fninf.2016.00020. eCollection 2016.

10.

Imaging Alzheimer's disease pathophysiology with PET.

Schilling LP, Zimmer ER, Shin M, Leuzy A, Pascoal TA, Benedet AL, Borelli WV, Palmini A, Gauthier S, Rosa-Neto P.

Dement Neuropsychol. 2016 Apr-Jun;10(2):79-90. doi: 10.1590/S1980-5764-2016DN1002003. Review.

11.

Amyloid-β and hyperphosphorylated tau synergy drives metabolic decline in preclinical Alzheimer's disease.

Pascoal TA, Mathotaarachchi S, Mohades S, Benedet AL, Chung CO, Shin M, Wang S, Beaudry T, Kang MS, Soucy JP, Labbe A, Gauthier S, Rosa-Neto P.

Mol Psychiatry. 2017 Feb;22(2):306-311. doi: 10.1038/mp.2016.37. Epub 2016 Mar 29.

12.

Epistasis analysis links immune cascades and cerebral amyloidosis.

Benedet AL, Labbe A, Lemay P, Zimmer ER, Pascoal TA, Leuzy A, Mathotaarachchi S, Mohades S, Shin M, Dionne-Laporte A, Beaudry T, Picard C, Gauthier S, Poirier J, Rouleau G, Rosa-Neto P; Alzheimer’s Disease Neuroimaging Initiative.

J Neuroinflammation. 2015 Dec 1;12:227. doi: 10.1186/s12974-015-0436-z.

13.

Tracking neuroinflammation in Alzheimer's disease: the role of positron emission tomography imaging.

Zimmer ER, Leuzy A, Benedet AL, Breitner J, Gauthier S, Rosa-Neto P.

J Neuroinflammation. 2014 Jul 8;11:120. doi: 10.1186/1742-2094-11-120. Review.

14.

Cytokine gene polymorphisms and Alzheimer's disease in Brazil.

Moraes CF, Benedet AL, Souza VC, Lins TC, Camargos EF, Naves JO, Brito CJ, Córdova C, Pereira RW, Nóbrega OT.

Neuroimmunomodulation. 2013;20(5):239-46. doi: 10.1159/000350368. Epub 2013 Jul 3.

PMID:
23838435
15.

Amerindian genetic ancestry protects against Alzheimer's disease.

Benedet AL, Moraes CF, Camargos EF, Oliveira LF, Souza VC, Lins TC, Henriques AD, Carmo DG, Machado-Silva W, Araújo CN, Córdova C, Pereira RW, Nóbrega OT.

Dement Geriatr Cogn Disord. 2012;33(5):311-7. doi: 10.1159/000339672. Epub 2012 Jul 2.

PMID:
22759767
16.

Dietary fat and apolipoprotein genotypes modulate plasma lipoprotein levels in Brazilian elderly women.

Paula RS, Souza VC, Benedet AL, Souza ER, Toledo JO, Moraes CF, Gomes L, Alho CS, Córdova C, Nóbrega OT.

Mol Cell Biochem. 2010 Apr;337(1-2):307-15. doi: 10.1007/s11010-009-0313-0.

PMID:
19915960

Supplemental Content

Loading ...
Support Center